标题
Bone health in cancer patients: ESMO Clinical Practice Guidelines
作者
关键词
-
出版物
ANNALS OF ONCOLOGY
Volume 25, Issue suppl 3, Pages iii124-iii137
出版商
Oxford University Press (OUP)
发表日期
2014-04-30
DOI
10.1093/annonc/mdu103
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Role of Denosumab for Prevention of Skeletal-Related Complications in Multiple Myeloma
- (2013) Kelly Hageman et al. ANNALS OF PHARMACOTHERAPY
- International Myeloma Working Group Recommendations for the Treatment of Multiple Myeloma–Related Bone Disease
- (2013) Evangelos Terpos et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy and safety of 12-weekly versus 4-weekly zoledronic acid for prolonged treatment of patients with bone metastases from breast cancer (ZOOM): a phase 3, open-label, randomised, non-inferiority trial
- (2013) Dino Amadori et al. LANCET ONCOLOGY
- Oral ibandronic acid versus intravenous zoledronic acid in treatment of bone metastases from breast cancer: a randomised, open label, non-inferiority phase 3 trial
- (2013) Peter Barrett-Lee et al. LANCET ONCOLOGY
- Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013
- (2013) J. Compston et al. MATURITAS
- Management of cancer treatment-induced bone loss
- (2013) Robert E. Coleman et al. Nature Reviews Rheumatology
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
- (2013) C. Parker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors
- (2013) David Henry et al. SUPPORTIVE CARE IN CANCER
- Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results
- (2012) R. Coleman et al. ANNALS OF ONCOLOGY
- Pain outcomes in patients with advanced breast cancer and bone metastases
- (2012) Charles S. Cleeland et al. CANCER
- Antiresorptive treatment options and bone health in cancer patients—safety profiles and clinical considerations
- (2012) Peyman Hadji et al. CANCER TREATMENT REVIEWS
- Cancer treatment-induced bone loss in premenopausal women: A need for therapeutic intervention?
- (2012) P. Hadji et al. CANCER TREATMENT REVIEWS
- Bone-Related Complications and Quality of Life in Advanced Breast Cancer: Results from a Randomized Phase III Trial of Denosumab versus Zoledronic Acid
- (2012) M. Martin et al. CLINICAL CANCER RESEARCH
- Population Pharmacokinetic Analysis of Denosumab in Patients with Bone Metastases from Solid Tumours
- (2012) Leonid Gibiansky et al. CLINICAL PHARMACOKINETICS
- Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials
- (2012) Allan Lipton et al. EUROPEAN JOURNAL OF CANCER
- Effects of androgen deprivation therapy and bisphosphonate treatment on bone in patients with metastatic castration-resistant prostate cancer: Results from the University of Washington Rapid Autopsy Series
- (2012) Colm Morrissey et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Bone-Targeted Agents on Cancer Progression and Mortality
- (2012) R. Coleman et al. JNCI-Journal of the National Cancer Institute
- Overall Survival Improvement in Patients with Lung Cancer and Bone Metastases Treated with Denosumab Versus Zoledronic Acid: Subgroup Analysis from a Randomized Phase 3 Study
- (2012) Giorgio Vittorio Scagliotti et al. Journal of Thoracic Oncology
- Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial
- (2012) Alexander HG Paterson et al. LANCET ONCOLOGY
- Denosumab in patients with cancer—a surgical strike against the osteoclast
- (2012) Janet E. Brown et al. Nature Reviews Clinical Oncology
- Cancer Response Criteria and Bone Metastases: RECIST 1.1, MDA and PERCIST
- (2012) Colleen M. Costelloe et al. Journal of Cancer
- Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases
- (2011) F. Saad et al. ANNALS OF ONCOLOGY
- Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment
- (2011) P. Hadji et al. ANNALS OF ONCOLOGY
- Bisphosphonates in oncology
- (2011) Robert E. Coleman et al. BONE
- Survival in breast cancer patients with bone metastases and skeletal-related events: a population-based cohort study in Denmark (1999–2007)
- (2011) Mellissa Yong et al. BREAST CANCER RESEARCH AND TREATMENT
- Consensus on the utility of bone markers in the malignant bone disease setting
- (2011) Robert Coleman et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- A comprehensive bone health management approach for men with prostate cancer receiving androgen deprivation therapy
- (2011) C.E. Lee et al. Current Oncology
- American Society of Clinical Oncology Executive Summary of the Clinical Practice Guideline Update on the Role of Bone-Modifying Agents in Metastatic Breast Cancer
- (2011) Catherine H. Van Poznak et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
- (2011) David H. Henry et al. JOURNAL OF CLINICAL ONCOLOGY
- Epidemiology and Treatment Costs of Bone Metastases from Lung Cancer: A French Prospective, Observational, Multicenter Study (GFPC 0601)
- (2011) Chantal Decroisette et al. Journal of Thoracic Oncology
- Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
- (2011) Karim Fizazi et al. LANCET
- Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial
- (2011) Matthew R Smith et al. LANCET
- Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial
- (2011) Gareth J Morgan et al. LANCET ONCOLOGY
- Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial
- (2011) Michael Gnant et al. LANCET ONCOLOGY
- Breast-Cancer Adjuvant Therapy with Zoledronic Acid
- (2011) Robert E. Coleman et al. NEW ENGLAND JOURNAL OF MEDICINE
- GRAND: the German retrospective cohort analysis on compliance and persistence and the associated risk of fractures in osteoporotic women treated with oral bisphosphonates
- (2011) P. Hadji et al. OSTEOPOROSIS INTERNATIONAL
- Bisphosphonate therapy in patients under androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis
- (2011) A Serpa Neto et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Hospital Resource Utilization and Treatment Cost of Skeletal-Related Events in Patients with Metastatic Breast or Prostate Cancer: Estimation for the Portuguese National Health System
- (2011) J. Félix et al. VALUE IN HEALTH
- Negative impact of bone metastasis on outcome in clear-cell renal cell carcinoma treated with sunitinib
- (2010) B. Beuselinck et al. ANNALS OF ONCOLOGY
- Bisphosphonates: Molecular Mechanisms of Action and Effects on Bone Cells, Monocytes and Macrophages
- (2010) A. J. Roelofs et al. CURRENT PHARMACEUTICAL DESIGN
- Perspective how many women have osteoporosis?
- (2010) L. Joseph Melton et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Prevention of Aromatase Inhibitor–Induced Bone Loss Using Risedronate: The SABRE Trial
- (2010) Catherine Van Poznak et al. JOURNAL OF CLINICAL ONCOLOGY
- Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
- (2010) Alison T. Stopeck et al. JOURNAL OF CLINICAL ONCOLOGY
- First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial
- (2010) Gareth J Morgan et al. LANCET
- Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial
- (2010) Peter Gimsing et al. LANCET ONCOLOGY
- Osteonecrosis of the jaw and bisphosphonates in cancer: a narrative review
- (2010) Cesar A. Migliorati et al. Nature Reviews Endocrinology
- The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network
- (2009) E. Terpos et al. ANNALS OF ONCOLOGY
- The Effects of Serum Testosterone, Estradiol, and Sex Hormone Binding Globulin Levels on Fracture Risk in Older Men
- (2009) Erin S. LeBlanc et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates
- (2009) Karim Fizazi et al. JOURNAL OF CLINICAL ONCOLOGY
- Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
- (2009) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- The effect of weight training on bone mineral density and bone turnover in postmenopausal breast cancer survivors with bone loss: a 24-month randomized controlled trial
- (2009) N. L. Waltman et al. OSTEOPOROSIS INTERNATIONAL
- Prevention of Anastrozole-Induced Bone Loss with Monthly Oral Ibandronate during Adjuvant Aromatase Inhibitor Therapy for Breast Cancer
- (2008) J. E. Lester et al. CLINICAL CANCER RESEARCH
- Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis
- (2008) Peyman Hadji CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Randomized Trial of Denosumab in Patients Receiving Adjuvant Aromatase Inhibitors for Nonmetastatic Breast Cancer
- (2008) Georgiana K. Ellis et al. JOURNAL OF CLINICAL ONCOLOGY
- FRAX™ and the assessment of fracture probability in men and women from the UK
- (2008) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started